APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Bacteria Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pneumococcal Bacteria Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026184 pages

Choose your research edition.

Industry ResearchPneumococcal Bacteria Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Bacteria Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pneumococcal Bacteria Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Bacteria Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Bacteria Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pneumococcal Bacteria Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pneumococcal Bacteria Vaccine include Sanofi, Merck, Pfizer, GSK, Walvax and Sinopharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pneumococcal Bacteria Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pneumococcal Bacteria Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pneumococcal Bacteria Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pneumococcal Bacteria Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pneumococcal Bacteria Vaccine Segment by Company

Sanofi

Merck

Pfizer

GSK

Walvax

Sinopharm

Pneumococcal Bacteria Vaccine Segment by Type

PPSV 23

PCV 13

PCV 10

Pneumococcal Bacteria Vaccine Segment by Application

Infant

Children

Adult

Pneumococcal Bacteria Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Bacteria Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Bacteria Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Bacteria Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pneumococcal Bacteria Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pneumococcal Bacteria Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pneumococcal Bacteria Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pneumococcal Bacteria Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pneumococcal Bacteria Vaccine Industry Trends Table 2. Pneumococcal Bacteria Vaccine Industry Drivers Table 3. Pneumococcal Bacteria Vaccine Industry Opportunities and Challenges Table 4. Pneumococcal Bacteria Vaccine Industry Restraints Table 5. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers Table 9. Global Pneumococcal Bacteria Vaccine Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Pneumococcal Bacteria Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pneumococcal Bacteria Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pneumococcal Bacteria Vaccine Manufacturers, Product Type & Application Table 13. Global Pneumococcal Bacteria Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pneumococcal Bacteria Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PPSV 23 Table 17. Major Manufacturers of PCV 13 Table 18. Major Manufacturers of PCV 10 Table 19. Global Pneumococcal Bacteria Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 20. Global Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 21. Global Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 22. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2021-2026) Table 23. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2027-2032) Table 24. Global Pneumococcal Bacteria Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 25. Global Pneumococcal Bacteria Vaccine Revenue by Type (2021-2026) & (K Doses) Table 26. Global Pneumococcal Bacteria Vaccine Revenue by Type (2027-2032) & (K Doses) Table 27. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Infant Table 30. Major Manufacturers of Children Table 31. Major Manufacturers of Adult Table 32. Global Pneumococcal Bacteria Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 33. Global Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 34. Global Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 35. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Pneumococcal Bacteria Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 38. Global Pneumococcal Bacteria Vaccine Revenue by Application (2021-2026) & (K Doses) Table 39. Global Pneumococcal Bacteria Vaccine Revenue by Application (2027-2032) & (K Doses) Table 40. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Pneumococcal Bacteria Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 43. Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2026) & (K Doses) Table 44. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Pneumococcal Bacteria Vaccine Sales Forecasted by Region (2027-2032) & (K Doses) Table 46. Global Pneumococcal Bacteria Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 48. North America Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 49. North America Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 50. Europe Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 51. Europe Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 52. Europe Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 53. Asia Pacific Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 54. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 55. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 56. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 57. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 58. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2027-2032) & (K Doses) Table 59. Global Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pneumococcal Bacteria Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pneumococcal Bacteria Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Pneumococcal Bacteria Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Pneumococcal Bacteria Vaccine Product Portfolio Table 68. Sanofi Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Pneumococcal Bacteria Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck Pneumococcal Bacteria Vaccine Product Portfolio Table 73. Merck Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Pneumococcal Bacteria Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Pneumococcal Bacteria Vaccine Product Portfolio Table 78. Pfizer Recent Development Table 79. GSK Company Information Table 80. GSK Business Overview Table 81. GSK Pneumococcal Bacteria Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GSK Pneumococcal Bacteria Vaccine Product Portfolio Table 83. GSK Recent Development Table 84. Walvax Company Information Table 85. Walvax Business Overview Table 86. Walvax Pneumococcal Bacteria Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Walvax Pneumococcal Bacteria Vaccine Product Portfolio Table 88. Walvax Recent Development Table 89. Sinopharm Company Information Table 90. Sinopharm Business Overview Table 91. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio Table 93. Sinopharm Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Pneumococcal Bacteria Vaccine Distributors List Table 97. Pneumococcal Bacteria Vaccine Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Pneumococcal Bacteria Vaccine Product Image Figure 2. Global Pneumococcal Bacteria Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Bacteria Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pneumococcal Bacteria Vaccine Sales (2021-2032) & (K Doses) Figure 5. Global Pneumococcal Bacteria Vaccine Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Pneumococcal Bacteria Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PPSV 23 Image Figure 9. PCV 13 Image Figure 10. PCV 10 Image Figure 11. Global Pneumococcal Bacteria Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 12. Global Pneumococcal Bacteria Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2021-2032) Figure 14. Global Pneumococcal Bacteria Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 15. Global Pneumococcal Bacteria Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2021-2032) Figure 17. Infant Image Figure 18. Children Image Figure 19. Adult Image Figure 20. Global Pneumococcal Bacteria Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 21. Global Pneumococcal Bacteria Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Pneumococcal Bacteria Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 24. Global Pneumococcal Bacteria Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 27. North America Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Canada Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Mexico Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 31. Europe Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 32. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. France Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. U.K. Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Italy Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Netherlands Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 38. Asia Pacific Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 39. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. Japan Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. South Korea Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. Southeast Asia Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. India Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. Australia Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 46. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 47. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. South Africa Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Saudi Arabia Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. Turkey Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. Argentina Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. UAE Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Egypt Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 55. Chile Pneumococcal Bacteria Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 56. Global Pneumococcal Bacteria Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pneumococcal Bacteria Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pneumococcal Bacteria Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • PPSV 23
  • PCV 13
  • PCV 10
Applications
  • Infant
  • Children
  • Adult
Companies covered
  • Sanofi
  • Merck
  • Pfizer
  • GSK
  • Walvax
  • Sinopharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pneumococcal Bacteria Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pneumococcal Bacteria Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pneumococcal Bacteria Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pneumococcal Bacteria Vaccine Market Dynamics
  1. 2.1 Pneumococcal Bacteria Vaccine Industry Trends
  2. 2.2 Pneumococcal Bacteria Vaccine Industry Drivers
  3. 2.3 Pneumococcal Bacteria Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Bacteria Vaccine Industry Restraints
3 Pneumococcal Bacteria Vaccine Market by Manufacturers
  1. 3.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pneumococcal Bacteria Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pneumococcal Bacteria Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pneumococcal Bacteria Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pneumococcal Bacteria Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Pneumococcal Bacteria Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pneumococcal Bacteria Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pneumococcal Bacteria Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pneumococcal Bacteria Vaccine Tier 1, Tier 2, and Tier 3
4 Pneumococcal Bacteria Vaccine Market by Type
  1. 4.1 Pneumococcal Bacteria Vaccine Type Introduction
  2. 4.1.1 PPSV 23
  3. 4.1.2 PCV 13
  4. 4.1.3 PCV 10
  5. 4.2 Global Pneumococcal Bacteria Vaccine Sales by Type
  6. 4.2.1 Global Pneumococcal Bacteria Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pneumococcal Bacteria Vaccine Sales by Type (2021-2032)
  8. 4.2.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pneumococcal Bacteria Vaccine Revenue by Type
  10. 4.3.1 Global Pneumococcal Bacteria Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pneumococcal Bacteria Vaccine Revenue by Type (2021-2032)
  12. 4.3.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2021-2032)
5 Pneumococcal Bacteria Vaccine Market by Application
  1. 5.1 Pneumococcal Bacteria Vaccine Application Introduction
  2. 5.1.1 Infant
  3. 5.1.2 Children
  4. 5.1.3 Adult
  5. 5.2 Global Pneumococcal Bacteria Vaccine Sales by Application
  6. 5.2.1 Global Pneumococcal Bacteria Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pneumococcal Bacteria Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pneumococcal Bacteria Vaccine Revenue by Application
  10. 5.3.1 Global Pneumococcal Bacteria Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pneumococcal Bacteria Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2021-2032)
6 Global Pneumococcal Bacteria Vaccine Sales by Region
  1. 6.1 Global Pneumococcal Bacteria Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Pneumococcal Bacteria Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pneumococcal Bacteria Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pneumococcal Bacteria Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pneumococcal Bacteria Vaccine Revenue by Region
  1. 7.1 Global Pneumococcal Bacteria Vaccine Revenue by Region
  2. 7.1.1 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pneumococcal Bacteria Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Pneumococcal Bacteria Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pneumococcal Bacteria Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pneumococcal Bacteria Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pneumococcal Bacteria Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pneumococcal Bacteria Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pneumococcal Bacteria Vaccine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Pneumococcal Bacteria Vaccine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Pneumococcal Bacteria Vaccine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK Pneumococcal Bacteria Vaccine Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 Walvax
  26. 8.5.1 Walvax Company Information
  27. 8.5.2 Walvax Business Overview
  28. 8.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Walvax Pneumococcal Bacteria Vaccine Product Portfolio
  30. 8.5.5 Walvax Recent Developments
  31. 8.6 Sinopharm
  32. 8.6.1 Sinopharm Company Information
  33. 8.6.2 Sinopharm Business Overview
  34. 8.6.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio
  36. 8.6.5 Sinopharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pneumococcal Bacteria Vaccine Value Chain Analysis
  2. 9.1.1 Pneumococcal Bacteria Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pneumococcal Bacteria Vaccine Production Mode & Process
  6. 9.2 Pneumococcal Bacteria Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pneumococcal Bacteria Vaccine Distributors
  9. 9.2.3 Pneumococcal Bacteria Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst